98%
921
2 minutes
20
OrthoNets use the Gram-Schmidt process to achieve orthogonality among filters but do not impose constraints on the internal orthogonality of individual filters. To reduce the risk of overfitting, especially in scenarios with limited data such as medical image, this study explores an enhanced network that ensures the internal orthogonality within individual filters, named the Orthogonal Channel Shuffle Network ( OSNet). This network is integrated into the Detection Transformer (DETR) framework for brain tumor detection, resulting in the OS-DETR. To further optimize model performance, this study also incorporates deformable attention mechanisms and an Intersection over Union strategy that emphasizes the internal region influence of bounding boxes and the corner distance disparity. Experimental results on the Br35H brain tumor dataset demonstrate the significant advantages of OS-DETR over mainstream object detection frameworks. Specifically, OS-DETR achieves a Precision of 95.0%, Recall of 94.2%, mAP@50 of 95.7%, and mAP@50:95 of 74.2%. The code implementation and experimental results are available at https://github.com/dkx2077/OS-DETR.git.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074655 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0320757 | PLOS |
Nat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFEMBO Mol Med
September 2025
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, 100071, Beijing, China.
Traditional live attenuated vaccines (LAVs) are typically developed through serial passaging or genetic engineering to introduce specific mutations or deletions. While viral RNA secondary or tertiary structures have been well-documented for their multiple functions, including binding with specific host proteins, their potential for LAV design remains largely unexplored. Herein, using Zika virus (ZIKV) as a model, we demonstrate that targeted disruption of the primary sequence or tertiary structure of a specific viral RNA element responsible for Musashi-1 (MSI1) binding leads to a tissue-specific attenuation phenotype in multiple animal models.
View Article and Find Full Text PDFJ Hum Genet
September 2025
Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Comprehensive genomic profiling (CGP) expands treatment options for solid tumor patients and identifies hereditary cancers. However, in Japan, confirmatory tests have been conducted in only 31.6% of patients with presumed germline pathogenic variants (GPVs) detected through tumor-only testing.
View Article and Find Full Text PDFExp Neurobiol
August 2025
Institute of Medical Science, Ajou University School of Medicine, Suwon 16499, Korea.
Neural tumors represent diverse malignancies with distinct molecular profiles and present particular challenges due to the blood-brain barrier, heterogeneous molecular etiology including epigenetic dysregulation, and the affected organ's critical nature. KCC-07, a selective and blood-brain barrier penetrable MBD2 (methyl CpG binding domain protein 2) inhibitor, can suppress tumor development by inducing p53 signaling, proven only in medulloblastoma. Here we demonstrate KCC-07 treatment's application to other neural tumors.
View Article and Find Full Text PDFMed Eng Phys
October 2025
Biomedical Device Technology, Istanbul Aydın University, Istanbul, 34093, Istanbul, Turkey. Electronic address:
Deep learning approaches have improved disease diagnosis efficiency. However, AI-based decision systems lack sufficient transparency and interpretability. This study aims to enhance the explainability and training performance of deep learning models using explainable artificial intelligence (XAI) techniques for brain tumor detection.
View Article and Find Full Text PDF